Steinunn Erla Thorlacius, the CEO of Intuens, has refuted criticism from health professionals who argue that the company's health screening service is harmful rather than beneficial. This backlash highlights a growing tension between traditional healthcare and innovative health solutions, with many experts asserting that such services hinder genuine medical progress. Thorlacius insists that the negative reactions are merely a defense of entrenched interests within the healthcare system.

Intuens's health screening, which aims to provide early detection of illnesses, has gained significant attention, particularly due to a rise in personal testimonials shared on social media. Critics, including the heads of cancer and family medicine associations, have voiced strong opposition, stating that the screenings may lead to unnecessary anxiety and could result in misdiagnoses, instead of the intended informative purpose.

The debate surrounding Intuens and its health screening service underscores broader issues within healthcare innovation—whether new approaches are truly embraced or if they are met with resistance from established practitioners. As Intuens responds to the criticism, the outcome could have significant implications for the evolution of health services in Iceland, raising questions about the balance between innovation and tradition in medical practice.